Mesenchymal Stromal Cells Mediate Clinically Unpromising but Favourable Immune Responses in Kidney Transplant Patients
Urvashi Kaundal(Post Graduate Institute of Medical Education and Research), Aruna Rakha(Post Graduate Institute of Medical Education and Research), Mukut Minz(Post Graduate Institute of Medical Education and Research), Vivekanand Jha(The George Institute for Global Health), Deepesh Benjamin Kenwar(Post Graduate Institute of Medical Education and Research), Amit Arora(Post Graduate Institute of Medical Education and Research), Raja Ramachandran(Post Graduate Institute of Medical Education and Research), Ritambhra Nada(Post Graduate Institute of Medical Education and Research), Ratti Ram Sharma(Post Graduate Institute of Medical Education and Research)
Cited by 5
Related Papers
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Nephrology Dialysis Transplantation|2019|587
Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy
|Clinical Journal of the American Society of Nephrology|2016|473